Mazzotti reaction after presumptive treatment for schistosomiasis and strongyloidiasis in a Liberian refugee

Pediatric Infectious Disease Journal

Volumn 25, Issue 5, 2006, Pages 466-468

  Olson, Bradley G ^a,b   Domachowske, Joseph B ^a  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b Department of Pediatrics ^*  (United States)

Author keywords

Mazzotti reaction; Onchocerciasis; Refugee medicine; Schistosomiasis; Strongyloidiasis

Indexed keywords

ALBENDAZOLE; ANTIPARASITIC AGENT; DIETHYLCARBAMAZINE; DIPHENHYDRAMINE; ISONIAZID; IVERMECTIN; METHYLPREDNISOLONE; PRAZIQUANTEL;

ABDOMINAL PAIN; ADOLESCENT; APPLICATION SITE PRURITUS; ARTICLE; CASE REPORT; DRUG SAFETY; FEVER; HUMAN; LIBERIA; MALE; MAZZOTTI REACTION; ONCHOCERCIASIS; PRIORITY JOURNAL; REFUGEE; SCHISTOSOMIASIS; STRONGYLOIDIASIS; SYMPTOMATOLOGY; TREATMENT OUTCOME; TUBERCULOSIS; URTICARIA; VOMITING;

ADOLESCENT; ALBENDAZOLE; ANIMALS; ANTHELMINTICS; HUMANS; IVERMECTIN; LIBERIA; MALE; PRAZIQUANTEL; REFUGEES; SCHISTOSOMIASIS; STRONGYLOIDIASIS;

EID: 33646762433     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000217415.68892.0c     Document Type: Article

References (10)

1. Center for Disease Control and Prevention. Recommendations for presumptive treatment of schistosomiasis and strongyloidiasis among the Lost Boys and Girls of Sudan and other Sudanese refugees. Available at: http:// www.cdc.gov/ncidod/dq/pdf/Overseas_Domestic_Pres_Tx_Rec_Sudanese_ 6-13-05.pdf (updated 2005 Jun 13; cited August 29, 2005).
2. Center for Disease Control and Prevention. Recommendations for presumptive treatment of schistosomiasis and strongyloidiasis among the Somali Bantu refugees. Available at: http://www.cdc.gov/ncidod/dq/pdf/ Overseas%20_Domestic_Pres_Tx_Rec_Somali_Bantu_6-13-05.pdf (updated 2005 Jun 13; cited August 29, 2005).
3. Mazzotti, L. Onchocerciasis in Mexico. In: Proceedings of the 4th International Congress of Tropical Medicine: Malarias (Session 1 of 6), Washington D.C.; 1948:948-56.
4. Twum-Danso N. Serious adverse events following treatment with Ivermectin for onchocerciasis control: a review of reported cases. Filaria Journal. 2003;2(suppl 1):S3.
5. Greene BM, Taylor HR, Cupp EW, et al. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Eng J Med. 1985;313:133-138.
6. Cooper PJ, Awadzi K, Ottesen EA, Remick D, Nutman TB. Eosinophil sequestration and activation are associated with the onset and severity of systemic adverse reactions following the treatment of onchocerciasis with ivermectin. J Infect Dis. 1999;179:738-742.
7. Francis H, Awadzi K, Ottesen EA. The Mazzotti reaction following treatment of onchocerciasis with diethylcarbamazine: clinical severity as a function of infection intensity. Am J Tro Med Hyg. 1985;34:529-536.
8. Gibson DW, Heggie C, Connor DH. Clinical and pathologic aspects of onchocerciasis. Pathol Annu. 1980;15:195-199.
9. Keiser PB, Reynolds SM, Awadzi K, Ottesen EA, Taylor MJ, Nutman TB. Bacterial endosymbionts of Onchocerca volvulus in the pathogenesis of post treatment reactions. J Infect Dis. 2002;185:805-811.
10. Stingl P, Pierce PF, Connor DH, et al. Does dexamethasone suppress the Mazzotti reaction in patients with onchocerciasis? Acta Trop. 1988;45:77-85.